Short Bowel Syndrome Market Research Report by Drug Class (GLP-2, Glutamine, and Growth Hormone) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Short Bowel Syndrome Market is expected to grow from USD 864.06 Million in 2020 to USD 2,005.56 Million by the end of 2025.
2. The Global Short Bowel Syndrome Market is expected to grow from EUR 757.62 Million in 2020 to EUR 1,758.51 Million by the end of 2025.
3. The Global Short Bowel Syndrome Market is expected to grow from GBP 673.53 Million in 2020 to GBP 1,563.32 Million by the end of 2025.
4. The Global Short Bowel Syndrome Market is expected to grow from JPY 92,217.53 Million in 2020 to JPY 214,044.58 Million by the end of 2025.
5. The Global Short Bowel Syndrome Market is expected to grow from AUD 1,254.73 Million in 2020 to AUD 2,912.34 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Short Bowel Syndrome to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Short Bowel Syndrome Market studied across GLP-2, Glutamine, and Growth Hormone.
Based on Geography, the Short Bowel Syndrome Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Short Bowel Syndrome Market including Ardelyx Inc, Emmaus Life Sciences, GlyPharma Therapeutics, Merck KGaA, Naia Pharmaceuticals, Nutrinia Ltd, OxThera, Sancilio & Company Inc, Shire plc, and Zealand Pharma A/S.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Short Bowel Syndrome Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Short Bowel Syndrome Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Short Bowel Syndrome Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Short Bowel Syndrome Market?
4. What is the competitive strategic window for opportunities in the Global Short Bowel Syndrome Market?
5. What are the technology trends and regulatory frameworks in the Global Short Bowel Syndrome Market?
6. What are the modes and strategic moves considered suitable for entering the Global Short Bowel Syndrome Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Short Bowel Syndrome Market is expected to grow from USD 864.06 Million in 2020 to USD 2,005.56 Million by the end of 2025.
2. The Global Short Bowel Syndrome Market is expected to grow from EUR 757.62 Million in 2020 to EUR 1,758.51 Million by the end of 2025.
3. The Global Short Bowel Syndrome Market is expected to grow from GBP 673.53 Million in 2020 to GBP 1,563.32 Million by the end of 2025.
4. The Global Short Bowel Syndrome Market is expected to grow from JPY 92,217.53 Million in 2020 to JPY 214,044.58 Million by the end of 2025.
5. The Global Short Bowel Syndrome Market is expected to grow from AUD 1,254.73 Million in 2020 to AUD 2,912.34 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Short Bowel Syndrome to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Short Bowel Syndrome Market studied across GLP-2, Glutamine, and Growth Hormone.
Based on Geography, the Short Bowel Syndrome Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Short Bowel Syndrome Market including Ardelyx Inc, Emmaus Life Sciences, GlyPharma Therapeutics, Merck KGaA, Naia Pharmaceuticals, Nutrinia Ltd, OxThera, Sancilio & Company Inc, Shire plc, and Zealand Pharma A/S.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Short Bowel Syndrome Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Short Bowel Syndrome Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Short Bowel Syndrome Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Short Bowel Syndrome Market?
4. What is the competitive strategic window for opportunities in the Global Short Bowel Syndrome Market?
5. What are the technology trends and regulatory frameworks in the Global Short Bowel Syndrome Market?
6. What are the modes and strategic moves considered suitable for entering the Global Short Bowel Syndrome Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL SHORT BOWEL SYNDROME MARKET, BY DRUG CLASS
6.1. Introduction
6.2. GLP-2
6.3. Glutamine
6.4. Growth Hormone
7. AMERICAS SHORT BOWEL SYNDROME MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Ardelyx Inc
11.2. Emmaus Life Sciences
11.3. GlyPharma Therapeutics
11.4. Merck KGaA
11.5. Naia Pharmaceuticals
11.6. Nutrinia Ltd
11.7. OxThera
11.8. Sancilio & Company Inc
11.9. Shire plc
11.10. Zealand Pharma A/S
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL SHORT BOWEL SYNDROME MARKET, BY DRUG CLASS
6.1. Introduction
6.2. GLP-2
6.3. Glutamine
6.4. Growth Hormone
7. AMERICAS SHORT BOWEL SYNDROME MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Ardelyx Inc
11.2. Emmaus Life Sciences
11.3. GlyPharma Therapeutics
11.4. Merck KGaA
11.5. Naia Pharmaceuticals
11.6. Nutrinia Ltd
11.7. OxThera
11.8. Sancilio & Company Inc
11.9. Shire plc
11.10. Zealand Pharma A/S
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GLP-2, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GLUTAMINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROWTH HORMONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AUSTRALIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CHINA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. INDIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDONESIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. JAPAN SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MALAYSIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. PHILIPPINES SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. SOUTH KOREA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. THAILAND SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. NETHERLANDS SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. QATAR SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL SHORT BOWEL SYNDROME MARKET: SCORES
TABLE 40. GLOBAL SHORT BOWEL SYNDROME MARKET: BUSINESS STRATEGY
TABLE 41. GLOBAL SHORT BOWEL SYNDROME MARKET: PRODUCT SATISFACTION
TABLE 42. GLOBAL SHORT BOWEL SYNDROME MARKET: RANKING
TABLE 43. GLOBAL SHORT BOWEL SYNDROME MARKET: MERGER & ACQUISITION
TABLE 44. GLOBAL SHORT BOWEL SYNDROME MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 45. GLOBAL SHORT BOWEL SYNDROME MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 46. GLOBAL SHORT BOWEL SYNDROME MARKET: INVESTMENT & FUNDING
TABLE 47. GLOBAL SHORT BOWEL SYNDROME MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 48. GLOBAL SHORT BOWEL SYNDROME MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GLP-2, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GLUTAMINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROWTH HORMONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AUSTRALIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CHINA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. INDIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDONESIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. JAPAN SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MALAYSIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. PHILIPPINES SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. SOUTH KOREA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. THAILAND SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. NETHERLANDS SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. QATAR SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL SHORT BOWEL SYNDROME MARKET: SCORES
TABLE 40. GLOBAL SHORT BOWEL SYNDROME MARKET: BUSINESS STRATEGY
TABLE 41. GLOBAL SHORT BOWEL SYNDROME MARKET: PRODUCT SATISFACTION
TABLE 42. GLOBAL SHORT BOWEL SYNDROME MARKET: RANKING
TABLE 43. GLOBAL SHORT BOWEL SYNDROME MARKET: MERGER & ACQUISITION
TABLE 44. GLOBAL SHORT BOWEL SYNDROME MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 45. GLOBAL SHORT BOWEL SYNDROME MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 46. GLOBAL SHORT BOWEL SYNDROME MARKET: INVESTMENT & FUNDING
TABLE 47. GLOBAL SHORT BOWEL SYNDROME MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 48. GLOBAL SHORT BOWEL SYNDROME MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL SHORT BOWEL SYNDROME MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL SHORT BOWEL SYNDROME MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL SHORT BOWEL SYNDROME MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL SHORT BOWEL SYNDROME MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 13. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 15. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GLP-2, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GLUTAMINE, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROWTH HORMONE, 2020 VS 2025 (USD MILLION)
FIGURE 18. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 19. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 21. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 22. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 27. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 29. AUSTRALIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. CHINA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. INDIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDONESIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. JAPAN SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. MALAYSIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. PHILIPPINES SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. SOUTH KOREA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. THAILAND SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. NETHERLANDS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. QATAR SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. GLOBAL SHORT BOWEL SYNDROME MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL SHORT BOWEL SYNDROME MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 54. GLOBAL SHORT BOWEL SYNDROME MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 55. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SHORT BOWEL SYNDROME MARKET, BY TYPE
FIGURE 1. GLOBAL SHORT BOWEL SYNDROME MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL SHORT BOWEL SYNDROME MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL SHORT BOWEL SYNDROME MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL SHORT BOWEL SYNDROME MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 13. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 15. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GLP-2, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GLUTAMINE, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL SHORT BOWEL SYNDROME MARKET SIZE, BY GROWTH HORMONE, 2020 VS 2025 (USD MILLION)
FIGURE 18. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 19. AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 21. ARGENTINA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 22. BRAZIL SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. CANADA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. MEXICO SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. UNITED STATES SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 27. ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 29. AUSTRALIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. CHINA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. INDIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDONESIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. JAPAN SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. MALAYSIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. PHILIPPINES SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. SOUTH KOREA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. THAILAND SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. FRANCE SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. GERMANY SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ITALY SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. NETHERLANDS SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. QATAR SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. RUSSIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. SAUDI ARABIA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH AFRICA SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SPAIN SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. UNITED ARAB EMIRATES SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED KINGDOM SHORT BOWEL SYNDROME MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. GLOBAL SHORT BOWEL SYNDROME MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL SHORT BOWEL SYNDROME MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 54. GLOBAL SHORT BOWEL SYNDROME MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 55. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SHORT BOWEL SYNDROME MARKET, BY TYPE
